Clinical impact of urinary CD11b and CD163 on the renal outcomes of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Yuki YokoeNaotake TsuboiTakahiro ImaizumiAkimitsu KitagawaMunetoshi KarasawaTakaya OzekiNobuhide EndoYuriko SawaSawako KatoTakayuki KatsunoShoichi MaruyamaKunihiro YamagataJoichi UsuiMichio NagataKen-Ei SadaHitoshi SugiyamaKoichi AmanoYoshihiro ArimuraTatsuya AtsumiYukio YuzawaHiroaki DobashiYoshinari TakasakiMasayoshi HarigaiHitoshi HasegawaHirofumi MakinoSeiichi Matsuonull null

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2021)

Although both U-CD11b and U-CD163 reflect renal leukocyte accumulation, U-CD11b at diagnosis provides additional clinical value by predicting the recovery rate after the treatment of ANCA-GN.

Keyphrases

nk cells
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle
replacement therapy